Just had dinner with a friend this past weekend who is down a significant amount of weight but is still making bad dietary choices and is not exercising
Neuroinflammation in Parkinsons disease and related disorders: a lesson from genetically manipulated mouse models of alpha-synucleinopathies
INTRODUCTION The recent and rapid rise of the GLP-1 receptor agonists semaglutide (Ozempic, Rybelsus and Wegovy) and tirzepatide (Mounjaro and Zepbound) offers a critical lens through which we can examine the intersection of financialization, patent abuse, and health inequities in the pharmaceutical industry
It works by: Enhancing insulin secretion in a glucose-dependent manner, which helps lower blood sugar without causing hypoglycemia when used alone Suppressing glucagon release from the pancreas, reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on central appetite centers in the hypothalamus to decrease food intake Semaglutide is administered subcutaneously (Ozempic, Wegovy) or orally (Rybelsus) and is primarily eliminated via proteolytic degradation, not through hepatic cytochrome P450 enzymes
"The ingredients include a technology that harnesses potent antioxidants found in Vitis Flower Stem Cell Extract, Peptide Complex to support rejuvenation and hydration, and Polysaccharides from French Polynesia for healthy-looking skin, all working to support skin's ability to replenish its own hyaluronic acid for overall skin health." Another favorite for Dr